MAPT and hyperhomocysteinemia: Li et al. (79) demonstrated that hyperhomocysteinemia epigenetically controls gene expression in the amyloid pathway increasing amyloid deposition in the brain along with phosphorylated tau production (p-Tau), leading to hippocampal neuron death as well as various cognitive deficits.